Literature DB >> 28765004

FDA licensure of and ACIP recommendations for vaccines.

Larry K Pickering1, Walter A Orenstein2, Wellington Sun3, Carol J Baker4.   

Abstract

Many healthcare providers are not familiar with the Food and Drug Administration (FDA) vaccine licensure process, the Advisory Committee on Immunization Practices (ACIP) vaccine recommendation process, and how FDA vaccine licensure and ACIP recommendations are related. Vaccines for use in the United States military and civilian populations are licensed by the FDA by several potential pathways but use of licensed vaccines in the civilian population should be based on recommendations made by the ACIP. In performing these distinct activities, FDA and ACIP function under different mandates. In this article, we discuss whether the FDA licensure pathways used to approve a vaccine impacts ACIP recommendation categories for vaccines licensed from 2006 to 2016.
Copyright © 2017 Elsevier Ltd. All rights reserved.

Keywords:  ACIP; CDC; FDA; Licensure; Policy; Recommendation; Vaccines

Mesh:

Year:  2017        PMID: 28765004     DOI: 10.1016/j.vaccine.2017.07.023

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  4 in total

1.  Understanding FDA-Approved Labeling and CDC Recommendations for Use of Vaccines.

Authors:  H Cody Meissner; Karen Farizo; Douglas Pratt; Larry K Pickering; Amanda C Cohn
Journal:  Pediatrics       Date:  2018-09       Impact factor: 7.124

Review 2.  Understanding Vaccine Safety and the Roles of the FDA and the CDC.

Authors:  H Cody Meissner
Journal:  N Engl J Med       Date:  2022-04-28       Impact factor: 176.079

3.  How Do Experts and Nonexperts Want to Promote Vaccines? Hepatitis E Vaccine as Example.

Authors:  Hong Ren; Abram L Wagner; Jia-Yu Xie; Kai-Yun Chen; Yi-Han Lu; Xu-Bin Zheng; Tao Huang; Matthew L Boulton; Xiang-Xiang Chen
Journal:  Health Serv Insights       Date:  2019-12-26

4.  How health care providers should address vaccine hesitancy in the clinical setting: Evidence for presumptive language in making a strong recommendation.

Authors:  Robert M Jacobson; Jennifer L St Sauver; Joan M Griffin; Kathy L MacLaughlin; Lila J Finney Rutten
Journal:  Hum Vaccin Immunother       Date:  2020-04-03       Impact factor: 3.452

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.